Bioavailability and pharmacokinetic parameters for 5-ethyl-2'-deoxyuridine.

[1]  L. Wiebe,et al.  Synthesis and biodistribution of [4-14C]-5-bromo-6-methoxy-5,6-dihydro-prodrug derivatives of 5-ethyl-2'-deoxyuridine. , 1994, Drug design and discovery.

[2]  L. Wiebe,et al.  Synthesis, biotransformation, pharmacokinetics, and antiviral properties of 5-ethyl-5-halo-6-methoxy-5,6-dihydro-2'-deoxyuridine diastereomers. , 1994, Biochemical pharmacology.

[3]  M. Shelton,et al.  Comparative Pharmacokinetics of Antiviral Nucleoside Analogues , 1993, Clinical pharmacokinetics.

[4]  W. M. Williams,et al.  Elimination of the antiviral drug 5-ethyl-2'-deoxyuridine by the isolated perfused rat liver. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[5]  J. Singer,et al.  Randomized, Double-Blind, Placebo-Controlled, Clinic-Initiated, Canadian Multicenter Trial of Topical Edoxudine 3.0% Cream in the Treatment of Recurrent Genital Herpes , 1991 .

[6]  H. Ishitsuka,et al.  Comparative Antitumor Activity and Intestinal Toxicity of 5′‐Deoxy‐5‐fluorouridine and Its Prodrug Trimethoxybenzoyl‐5′‐deoxy‐5‐fluorocytidine , 1990, Japanese journal of cancer research : Gann.

[7]  W. Voelter,et al.  [Metabolic studies of 5-ethyl-2'-deoxyuridine with liver extract, liver cells and liver cell culture]. , 1989, Arzneimittel-Forschung.

[8]  S. Broder,et al.  Plasma and cerebrospinal fluid pharmacokinetics of 3′‐azido‐3′‐deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases , 1987, Clinical pharmacology and therapeutics.

[9]  D. Tyrrell,et al.  Pharmacokinetics and metabolism of E-5-(2-[131I]iodovinyl)-2'-deoxyuridine in dogs , 1986, Antimicrobial Agents and Chemotherapy.

[10]  R. T. Walker,et al.  Chemotherapeutic agents for herpesvirus infections. , 1986, Progress in medicinal chemistry.

[11]  S. Spruance,et al.  Comparison of topically applied 5-ethyl-2'-deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigs , 1985, Antimicrobial Agents and Chemotherapy.

[12]  Elze Kl.  Ten years of clinical experiences with ethyldeoxyuridine. , 1979 .

[13]  J. Taylor,et al.  Effect of Treatment with 5-Ethyl-2′-Deoxyuridine on Herpes Simplex Virus Encephalitis in Normal and Immunosuppressed Mice , 1978, Antimicrobial Agents and Chemotherapy.

[14]  R. Sharma,et al.  Antiviral Action and Cellular Toxicity of Four Thymidine Analogues: 5-Ethyl-, 5-Vinyl-, 5-Propyl-, and 5-Allyl-2′-Deoxyuridine , 1976, Antimicrobial Agents and Chemotherapy.

[15]  E. De Clercq,et al.  Antiviral activity of 5-ethyl pyrimidine deoxynucleosides. , 1975, Biochemical pharmacology.

[16]  A. Martenet.  The Treatment of Experimental Deep Herpes Simplex Keratitis with Ethyl-Deoxy-Uridine and Iodo-Deoxy-Cytidine , 1975 .

[17]  D. Shugar,et al.  13-Alkylpyrimidine nucleosides. Preparation and properties of 5-ethyl-2'-deoxycytidine and related nucleosides. , 1974, Journal of medicinal chemistry.

[18]  D. Shugar,et al.  A nonmutagenic thymidine analog with antiviral activity. 5-Ethyldeoxyuridine. , 1969, Journal of medicinal chemistry.

[19]  Gauri Kk.  [Subconjunctival application of 5-ethyl-2'-desoxyuridine (EDU) for the chemotherapy of experimental herpetic keratitis in the rabbit]. , 1968 .

[20]  Welch Ad,et al.  A synopsis of recent investigations of 5-iodo-2'-deoxyuridine. , 1960 .